Luteinizing Hormone-Releasing Hormone Analog clinical trials

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

This study looks at a new drug called darolutamide, along with standard treatments like radiotherapy and hormone therapy, for men with prostate cancer that's at a very high risk of coming back. The aim is to see if this combination can better stop the cancer from spreading and improve their long-term health.